Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Fierce Pharma
FDA lays out plan to increase access to biosimilars
The FDA has revealed measures designed to increase the availability of biosimilars in the U.S. and in turn reduce the price of biologic medicines.
Kevin Dunleavy
Oct 29, 2025 3:45pm
Serve You Rx, Waltz Health partnership drives biosimilar use
Oct 16, 2025 1:01pm
PBM Serve You Rx to add 2 Stelara biosimilars to its formulary
Jun 5, 2025 1:15pm
Blue Shield to buy Humira biosimilar directly from manufacturer
Oct 2, 2024 3:00pm
Optum axes Humira from some of its preferred formularies: report
Sep 10, 2024 4:00pm
Accredo to make Stelara biosimilar available at $0 out-of-pocket
Sep 5, 2024 6:00am
